Real-time quantitative PCR demonstrates low prevalence of human papillomavirus type 16 in premalignant and malignant lesions of the oral cavity

Clinical Cancer Research

Volumn 8, Issue 5, 2002, Pages 1203-1209

  Ha, Patrick K ^a   Pai, Sara I ^a   Westra, William H ^a   Gillison, Maura L ^a   Tong, Betty C ^a   Sidransky, David ^a   Califano, Joseph A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARCINOGENESIS; DISEASE ASSOCIATION; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; MOUTH TUMOR; POLYMERASE CHAIN REACTION; PRECANCER; PREVALENCE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; DNA, VIRAL; FEMALE; HUMANS; MALE; MARYLAND; MIDDLE AGED; MOUTH; MOUTH NEOPLASMS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS; PREVALENCE; REPRESSOR PROTEINS; TIME FACTORS; TUMOR VIRUS INFECTIONS;

EID: 0036098009     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Association of human papillomavirus types 16 and 18 E6 proteins with p53
2. Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage
3. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers
4. Human papillomavirus in head and neck squamous cell carcinomas in nonsmokers
5. Human papillomavirus (HPV) in head and neck cancer. An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring
6. Viral gene detection in oral neoplasms using the polymerase chain reaction
7. Human papillomavirus (HPV) infections and their associations with oral disease
8. Human papillomavirus and cancers of the upper aerodigestive tract: A review of epidemiological and experimental evidence
9. "High risk" HPV types are frequently detected in potentially malignant and malignant oral lesions, but not in normal oral mucosa
10. Human papillomavirus infection in the malignant and premalignant head and neck epithelium
11. Human papillomavirus (HPV) DNA sequences in oral precancerous lesions and squamous cell carcinoma demonstrated by in situ hybridization
12. Detection of human papillomavirus DNA in oral mucosal lesions using in situ DNA-hybridization applied on paraffin sections
13. Human papilloma viruses in oral lesions
14. Genetic progression model for head and neck cancer: Implications for field cancerization
15. Human papillomavirus (HPV) is rarely present in normal oral and nasal mucosa
16. Human papillomaviruses in normal oral mucosa: A comparison of methods for sample collection
17. Low prevalence of human papillomavirus in a geographic region with a high incidence of head and neck cancer
18. Human papilloma viruses and p53 mutations in normal pre-malignant and malignant oral epithelia
19. Low detection rate of HPV in oral and laryngeal carcinomas
20. Detection of human papillomavirus-genomic DNA in oral epithelial dysplasias, oral smokeless tobacco-associated leukoplakias, and epithelial malignancies
21. Human papillomavirus expression in oral mucosa, premalignant conditions, and squamous cell carcinoma: A retrospective review of the literature
22. Detection and analysis of human papillomavirus 16 and 18 homologous DNA sequences in oral lesions
23. Detection of human papillomavirus DNA in biopsies of human oral tissue
24. Human papillomavirus in oral premalignant lesions
25. Detection of human papillomavirus DNA by in situ DNA hybridization and polymerase chain reaction in premalignant and malignant oral lesions
26. Prevalence of human papillomavirus infection in premalignant and malignant lesions of the oral cavity in U.K. subjects: A novel method of detection
27. Detection of HPV-16 genome in human oral cancers and potentially malignant lesions from India
28. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia
29. Detection and quantitation of human papillomavirus (HPV) DNA in the sera of patients with HPV-associated head and neck squamous cell carcinoma
30. Human papillomavims infection as a risk factor for squamous-cell carcinoma of the head and neck
31. Human papillomavirus infection and epidermal growth factor receptor expression in primary laryngeal squamous cell carcinoma